279 related articles for article (PubMed ID: 29084745)
21. Activity of Meropenem-Vaborbactam in Mouse Models of Infection Due to KPC-Producing Carbapenem-Resistant Enterobacteriaceae.
Sabet M; Tarazi Z; Nolan T; Parkinson J; Rubio-Aparicio D; Lomovskaya O; Dudley MN; Griffith DC
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29109160
[TBL] [Abstract][Full Text] [Related]
22. Determination of MIC and disk diffusion quality control guidelines for meropenem-vaborbactam, a novel carbapenem/boronic acid β-lactamase inhibitor combination.
Munson E; Huband MD; Castanheira M; Fedler KA; Flamm RK
Diagn Microbiol Infect Dis; 2018 Apr; 90(4):324-328. PubMed ID: 29276104
[TBL] [Abstract][Full Text] [Related]
23. Meropenem and Vaborbactam: Stepping up the Battle against Carbapenem-resistant Enterobacteriaceae.
Jorgensen SCJ; Rybak MJ
Pharmacotherapy; 2018 Apr; 38(4):444-461. PubMed ID: 29427523
[TBL] [Abstract][Full Text] [Related]
24. Activity of Meropenem-Vaborbactam against Carbapenem-Resistant Enterobacteriaceae in a Murine Model of Pyelonephritis.
Weiss WJ; Pulse ME; Nguyen P; Peterson K; Silva J; Simecka JW; Valtierra D; Sabet M; Griffith DC
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038270
[TBL] [Abstract][Full Text] [Related]
25. Meropenem/vaborbactam: a next generation β-lactam β-lactamase inhibitor combination.
Novelli A; Del Giacomo P; Rossolini GM; Tumbarello M
Expert Rev Anti Infect Ther; 2020 Jul; 18(7):643-655. PubMed ID: 32297801
[TBL] [Abstract][Full Text] [Related]
26. Activity of meropenem/vaborbactam and comparators against Gram-negative isolates from Eastern and Western European patients hospitalized with pneumonia including ventilator-associated pneumonia (2014-19).
Shortridge D; Carvalhaes C; Deshpande L; Castanheira M
J Antimicrob Chemother; 2021 Sep; 76(10):2600-2605. PubMed ID: 34302173
[TBL] [Abstract][Full Text] [Related]
27. Activity of Simulated Human Dosage Regimens of Meropenem and Vaborbactam against Carbapenem-Resistant Enterobacteriaceae in an
Sabet M; Tarazi Z; Rubio-Aparicio D; Nolan TG; Parkinson J; Lomovskaya O; Dudley MN; Griffith DC
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133570
[TBL] [Abstract][Full Text] [Related]
28. Phenotypes, genotypes and breakpoints: an assessment of β-lactam/ β-lactamase inhibitor combinations against OXA-48.
Asempa TE; Kois AK; Gill CM; Nicolau DP
J Antimicrob Chemother; 2022 Sep; 77(10):2622-2631. PubMed ID: 35325165
[TBL] [Abstract][Full Text] [Related]
29. Nacubactam Enhances Meropenem Activity against Carbapenem-Resistant Klebsiella pneumoniae Producing KPC.
Barnes MD; Taracila MA; Good CE; Bajaksouzian S; Rojas LJ; van Duin D; Kreiswirth BN; Jacobs MR; Haldimann A; Papp-Wallace KM; Bonomo RA
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182530
[TBL] [Abstract][Full Text] [Related]
30.
Nelson K; Rubio-Aparicio D; Sun D; Dudley M; Lomovskaya O
Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32482673
[TBL] [Abstract][Full Text] [Related]
31. Susceptibility of OXA-48-producing Enterobacterales to imipenem/relebactam, meropenem/vaborbactam and ceftazidime/avibactam.
Bonnin RA; Bernabeu S; Emeraud C; Creton E; Vanparis O; Naas T; Jousset AB; Dortet L
Int J Antimicrob Agents; 2022 Oct; 60(4):106660. PubMed ID: 35988666
[TBL] [Abstract][Full Text] [Related]
32. Activity of Imipenem-Relebactam and Meropenem-Vaborbactam against Carbapenem-Resistant, SME-Producing Serratia marcescens.
Biagi M; Shajee A; Vialichka A; Jurkovic M; Tan X; Wenzler E
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31932381
[TBL] [Abstract][Full Text] [Related]
33. Comparative evaluation of combined-disk tests using different boronic acid compounds for detection of klebsiella pneumoniae carbapenemase-producing enterobacteriaceae clinical isolates.
Tsakris A; Themeli-Digalaki K; Poulou A; Vrioni G; Voulgari E; Koumaki V; Agodi A; Pournaras S; Sofianou D
J Clin Microbiol; 2011 Aug; 49(8):2804-9. PubMed ID: 21632901
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of Human-Simulated Epithelial Lining Fluid Exposure of Meropenem-Nacubactam Combination against Class A Serine β-Lactamase-Producing
Asempa TE; Motos A; Abdelraouf K; Bissantz C; Zampaloni C; Nicolau DP
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670411
[TBL] [Abstract][Full Text] [Related]
35. Antimicrobial Activity of Ceftazidime-Avibactam Tested against Multidrug-Resistant Enterobacteriaceae and Pseudomonas aeruginosa Isolates from U.S. Medical Centers, 2013 to 2016.
Sader HS; Castanheira M; Shortridge D; Mendes RE; Flamm RK
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28827415
[TBL] [Abstract][Full Text] [Related]
36. Assessing the in vivo impact of novel β-lactamase inhibitors on the efficacy of their partner β-lactams against serine carbapenemase-producing Pseudomonas aeruginosa using human-simulated exposures.
Ruiz VH; Gill CM; Nicolau DP
J Antimicrob Chemother; 2024 Mar; 79(3):546-551. PubMed ID: 38217443
[TBL] [Abstract][Full Text] [Related]
37. Activity of Meropenem-Vaborbactam against Bacterial Isolates Causing Pneumonia in Patients in U.S. Hospitals during 2014 to 2018.
Carvalhaes CG; Shortridge D; Sader HS; Castanheira M
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31907187
[TBL] [Abstract][Full Text] [Related]
38.
Karlowsky JA; Hackel MA; Wise MG; Six DA; Uehara T; Daigle DM; Cusick SM; Pevear DC; Moeck G; Sahm DF
Antimicrob Agents Chemother; 2023 Jan; 67(1):e0128122. PubMed ID: 36541767
[TBL] [Abstract][Full Text] [Related]
39. Phenotypes, genotypes and breakpoints: an assessment of β-lactam/β-lactamase inhibitor combinations against OXA-48.
Asempa TE; Kois AK; Gill CM; Nicolau DP
J Antimicrob Chemother; 2023 Mar; 78(3):636-645. PubMed ID: 36626311
[TBL] [Abstract][Full Text] [Related]
40. A sensitive and specific phenotypic assay for detection of metallo-β-lactamases and KPC in Klebsiella pneumoniae with the use of meropenem disks supplemented with aminophenylboronic acid, dipicolinic acid and cloxacillin.
Giske CG; Gezelius L; Samuelsen Ø; Warner M; Sundsfjord A; Woodford N
Clin Microbiol Infect; 2011 Apr; 17(4):552-6. PubMed ID: 20597925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]